Research progress on the etiology and treatment of acquired paralytic strabismus
10.3980/j.issn.1672-5123.2026.4.19
- VernacularTitle:后天性麻痹性斜视病因与治疗的研究进展
- Author:
Shuting RU
1
;
Shuiling CHEN
1
;
Wanyu ZHOU
1
;
Wu SUN
1
;
Liqun CHU
1
Author Information
1. Department of Ophthalmology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China
- Publication Type:Journal Article
- Keywords:
acquired paralytic strabismus;
diplopia;
etiology;
treatment;
research progress
- From:
International Eye Science
2026;26(4):662-667
- CountryChina
- Language:Chinese
-
Abstract:
Acquired paralytic strabismus is a common neuromuscular disorder in adults,characterized by diplopia, visual confusion, impaired ocular motility, and ocular deviation, which severely affects the patient's quality of life and overall health. The disease has a complex etiology, encompassing multiple pathological mechanisms such as vascular pathologies, trauma, inflammation, neoplasms, and immune-related disorders. Treatment primarily focuses on addressing the underlying cause. While conventional Western approaches, such as medication and surgery, can alleviate symptoms, some carry the risk of adverse effects, and their long-term recurrence rates warrant careful consideration. Traditional Chinese medicine utilizes distinctive therapies such as herbal medicine, acupuncture, and other adjunctive therapies, which have shown promising therapeutic effects but are constrained by a lack of high-quality evidence from large-scale randomized controlled trials. This review systematically summarizes recent advances in the etiological classification and traditional Chinese and Western medical treatments of acquired paralytic strabismus. It innovatively summarizes the clinical features associated with different causes, analyzes current therapeutic strategies and research landscape, aiming to inform clinical practice and suggest future research directions.
